Status:
COMPLETED
Effect of Variance on Error Correction During Coupling
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
National MS Center Melsbroek
Revalidatie & MS Centrum Overpelt
Conditions:
Multiple Sclerosis
Progressive Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study is a case-control study, involving persons with progressive multiple sclerosis and healthy controls. The study contains 1 descriptive and 3 experimental sessions. In the descriptive session...
Eligibility Criteria
Inclusion
- diagnosis of Multiple sclerosis \>1 year, diagnosis of progressive MS,
- walking speed 0.8-1.2m/s, ability to walk for 6 minutes continuously (canes and rollators are permitted)
Exclusion
- relapse 3 months prior to enrollment,
- cognitive impairment impeding understanding of instructions,
- beat amusia,
- deafness,
- pregnancy
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04856384
Start Date
February 1 2021
End Date
December 31 2024
Last Update
February 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National MS Center Melsbroek
Melsbroek, Belgium, 1820
2
Noorderhart Revalidatie & MS centrum
Overpelt, Belgium, 3900